Author Archive

Dec

CFFC Facebook Posts – November 2019 – Part 2

11/16/2019 - Research Blast on... CFRD – Cystic Fibrosis Trust's quirky look at the pancreas and CFRD. 11/17/2019 - Deadline: CF Mental Health Survey – You have an opportunity to influence treatment guidelines for mental health. [Deadline is December 6th] 11/18/2019 - Patients Adhere Well to CFTR Therapies But High Costs Could Undermine Use, Pharmacy Study Says – With all the excitement generated by the approval of Trikafta, we're posting a two links today that provide some balance by looking at paying for the treatments. This link points to the impact of out-of-pocket-cost on dosage compliance. 11/18/2019 - Vertex Reaches Agreement for CF Medications in Northern Ireland and Wales – With all the excitement generated by the approval of Trikafta, we're posting a two links today that provide some balance by looking at paying for the treatments. This link reminds us that insurance coverage vary from country to country. 11/19/2019 - Interview: Ella Balasa Chats With CF Researcher About Phage Therapy – An individual who had successful phage therapy has a conversation about the treatment with the lead of the Foundation's Infection Research Initiative. 11/20/2019 - Disease-causing protein in cystic fibrosis has ancient roots in sea lamprey – A topic that arises in family experiencing CF is the ultimate source of the defective genes. This study indicates that the search has to go back millions of years. 11/21/2019 - UI Researchers Develop Breakthrough Approach to Gene Therapies for Respiratory Diseases – This study points to further advances in correcting CFTR mutations within ...

Nov

CFFC Facebook Posts – November 2019 – Part 1

11/02/2019 - Tools and Tips for Parents of Kids with CF – This page has links to a wide range of information resources for families of a child with CF. The topics cover issues faced by the family members as well as the challenges experienced by the child. 11/03/2019 - I Have Two Nonsense Mutations. Here’s What a Path to a Cure Means to Me – This blog post is a good reality check in the wake of the news about Trikafta. 11/04/2019 - Alaxia Joins iABC to Speed Development of ALX-009, Potential Antibiotic for Resistant Lung Infections – With the recent attention on the advance in CFTR modulators, it's important to also recognize the efforts being made to fight lung infections. 11/05/2019 – CF Roundtable Autumn 2019 - CF Roundtable is a great resource. The focus topic of this issue fits nicely with our recent coverage of CFTR modulators. The various stories will give you a good perspective whether or not you are currently using a CFTR modulator. 11/06/2019 - Cystic Fibrosis: The Physical and the Mental – We can't say it too often: mental health is an equal component in the challenge of CF. 11/07/2019 - CF research: this time it's personal – Here's a story from the UK about someone with CF (and not the first) taking an active role in solving the mysteries of CF. 11/08/2019 - $15 million cystic fibrosis research program launched – This announcement from the University Of Queensland (Australia) reminds us that research to combat CF's ...

Nov

CF Roundtable – Autumn 2019

The Autumn 2019 issue of CF Roundtable has just been released by United States Adult Cystic Fibrosis Assn. As usual, the newletter is chock full of useful information. The Autumn issue is particularly timely since the focus topic is CFTR modulators. You can access CF Roundtable in two formats. Just click the appropriate link below. Online Version PDF version As usual, the Editor's Notes gives you a good overview of the issues contents. I’ve got big shoes to fill in the wake of Kathy’s retirement. Kathy spent 29 years helping create, craft, and shape both the newsletter we all love so dearly and USACFA as an organization. It’s such an honor and privilege taking over as Managing Editor and I’m immensely grateful for the team of deeply passionate and committed people at CF Roundtable who work tirelessly to not only support the cystic fibrosis community but evolve our role in that support. Sadly, one of our former directors, instrumental in various columns, and secretary, Lisa Ann Cissell, passed away in August. You can read her obituary on page 44. Our focus topic this issue features so many incredible voices and stories about experiences with gene modulators. Jeanie Hanley details all the changes in her body after starting a modulator. Several people write about their bittersweet relationship with the new CFTR modulators while Hannah Schau writes about modulators saving her from trans-plant. We also feature several articles about the overwhelmingly positive impact CFTR modulators have had for many people. Kathy Russell shares her experiences on Orkambi in her column “Speeding Past 50.” In her wellness column, Julie Desch discusses what’s on the horizon with the triple combo modulator in the drug pipeline. In this issue, we announce both the re-launch of our Speakers Bureau program and the winners of our fall LMK scholarship, Sarah Salas and Alexandra Bannon. Beth Sufian answers questions regarding the ADA and FMLA in her column this month while Isabel Stenzel Byrnes talks about ambivalence in “Spirit Medicine.” Cindy Baldwin gives techniques for handling anxiety in children of CF parents in her column. We’re excited to share several new columns with readers this issue. To accompany our focus topic, Aimee Lecointre lists several quick bite ideas for adding variety to fatty snacks needed for modulator drugs. Kat Porco writes about the differences between ...

Nov

CFFC Facebook Posts – October 2019 – Part 2

10/16/2019 - Fall A Term: A Lot of Work, A Cold and More Fun – An update on Gunnar Esiaison's progress in grad school which provides insight on adaptation. 10/17/2019 - Preventing the Spread of Misinformation - [First of two companion articles.] In our rush to get news, we sometimes put too much reliance on the headline. 10/18/2019 - Orkambi of Definite Benefit But Risk Evident in Patients Who Can’t Tolerate It, French Study Finds – Applying the advice in the article posted yesterday, it's important to read this article all the way through to properly understand the information. 10/19/2019 - Living the Island Life With CF – Here's another story about how CF impacts – but does not control – the life you live. 10/20/2019 - Navigating CF: Choosing an Insurance Plan – In the open enrollment period for health insurance, we could all use help making choices that serve us best. CFF has produced an interactive guide to help you with your selection. 10/21/2019 - Ryan and Martin: a meeting of minds – This article demonstrates that good things can happen when researchers met people who are impacted by the research. 10/22/2019 - FDA approves new breakthrough therapy for cystic fibrosis – Hot off the presses. An additional CFTR modulator has been approved by the FDA. While this drug is applicable to those with at least on F508del mutation, the trials have shown that this combination works for individuals who did not benefit from previous combo drugs. 10/23/2019 – From CFF Community ...

Oct

Clinical Trial Alerts – October 2019

Cystic Fibrosis Foundation issued the following clinical trial alert in the month of October. October 16, 2019 Study of VX-445 triple combination in teens and adults with cystic fibrosis who have one copy of F508del and one copy of a gating or residual function mutation Status: Enrolling Description: This study will look at the safety and effectiveness of three CFTR modulators when taken in combination: VX-445 (elexacaftor), tezacaftor, and ivacaftor. CFTR modulators are drugs intended to help CFTR protein function closer to normal. Age: 12 Years and Older Mutation: One Copy F508del Fev1% Predicted: 40 to 90% Number of Visits: 8 Length of Participation: 20 weeks ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT04058353

Oct

CFFC Facebook Posts – October 2019 – Part 1

10/01/2019 - Best foods to eat with cystic fibrosis – Good news: this is a long list. 10/02/2019 - North American Cystic Fibrosis Conference (NACFC) – Read an announcement about this year's NACFC (including the opportunities to live stream) on the CFFC calendar. The announcement includes links to the program and registration. 10/03/2019 - Hexoskin Smart Shirt Can Accurately Assess Respiratory Function, May Be Tool in CF, Study Shows - “Wearable technology” may turn out to be more than a fad. Imagine lung funtion tests that don't require a trip to the clinic. 10/04/2019 - Parenthood After a Lung Transplant – As treatments advance, “parenthood” and “transplant” are two words becoming more common in the CF community. This blog puts these words together in a touching story. 10/05/2019 - Patient-derived Mini-organs Work as ‘Avatars’ to Test CF Treatments – The dream of personalized medications may becoming true in Australia. Exciting progress in the use a patient's own cells to test medications in the lab. 10/06/2019 - What to know about nitric oxide supplements – Nitric oxide is sometimes mentioned as an alternative medicine for CF. This article provides a broad analysis of the product. 10/07/2019 - Motocross Freed Me From CF Depression – We're not recommending motocross for everyone, but the message in this story is to find an activity that feeds your spirit. 10/08/2019 - Debunking the Myths About Vaccine Safety – As we enter the flu season, it is ...

Oct

CFFC Facebook Posts – September 2019 – Part 2

09/16/2019 – Living with CF Golf Tournament 2019 Results – Another successful event was held on Saturday the 14th. The golfers went home with prizes, but CFFC was the real winner. 09/17/2019 - Things You Shouldn’t Say to a Parent of a Child With CF – The blog author lists 7 things not to say. Have you heard them all? 09/19/2019 - Prenatal Testing for Cystic Fibrosis Influences Pregnancy Outcomes, Review Finds – The ethics associated with prenatal testing have been discussed ever since the identification of the CF gene. This article concludes with the recommendation for “nondirective counseling” when prenatal testing is being considered or has been conducted. 09/20/2019 - Knowing When You’ve Reached Your Limit (Then How to Effectively Communicate It and Reset) – Self awareness (listening to your body and responding accordingly) is a key element in maintaining your health. 09/21/2019 - The Power in Choosing with Kori Tolbert – CFFC past president Kori Tobert Doherty is dedicated to self advocacy and the power we have to influence the outcome of our healthcare. In this podcast, she discusses the principles and goals of her Booster Jots program. 09/22/2019 - Avoiding CF Information Overload – Is it odd for a CF internet source to suggest caution in internet CF sources? Well, there are some useful tips in this blog. 09/23/2019 - Physical Activity Levels in CF Should Be Objectively Researched, Review Says – Sometimes, we don't need studies to reveal the nature of CF treatments; however, the study suggests that properly defined research could lead to ...

Sep

Publications from Cystic Fibrosis Australia

Cystic Fibrosis Australia has produced a wide range of brochures covering all aspects of life with CF. While some of the material is specific to Australia, the majority of the information is relevant to anyone living with CF or wanting to know more about CF. You can find these resources at Facts, Figures and Publications. We have also added a link to our Information Resources, Life with CF section. The brochures are arranged in the following categories: Carrier Screening and diagnosis Medications and procedures School life Physiotherapy CF FIT Nutrition Hospital Germs Comorbidities (continence, bone health and CFRD) Lung Transplant Carers Sexual Health and Fertility Travel Climate Change and CF Exercise and Sport Each topic provides links to PDF brochures dealing with various aspects of that topic. For example, the Carrier Screening and Diagnosis section includes brochures entitled: "New Diagnosis Information for Parents," "Carrier Screening" and "Sweat Test." The brochures are written in an easy-to-read style. Breaking the information into multiple sections not only helps you deal with information overload, but also makes it easier to focus on the topic of most interest to you.

Sep

Clinical Trial Alerts – September 2019

Cystic Fibrosis Foundation issued the following clinical trial alerts in the month of September. September 17, 2019 Study of QBW276 in adults with CF Status: Completed with results Description: This study evaluated the safety and tolerability of QBW276, an inhaled drug designed to improve mucus clearance. This study also evaluated how the body processes the drug. Age: 18 Years and Older Mutation: No Mutation Requirement Fev1% Predicted: 40 to 100% Number of Visits: 6 Length of Participation: 14 days ClinicalTrials.gov link: https://www.clinicaltrials.gov/ct2/show/NCT02566044 Study of adherence to lumacaftor/ivacaftor using a smart pill bottle device Status: Completed with results Description: This study evaluated the impact of a smart pill bottle device on adherence to lumacaftor/ivacaftor (Orkambi®).This study was for people with CF who were not currently being treated with lumacaftor/ivacaftor (Orkambi®) prior to enrolling in the study. Age: 16 Years and Older Mutation: Two Copies F508del Fev1% Predicted: 40% or greater Number of Visits: 7 Length of Participation: 48 weeks ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT02823470 Study of VX-661 plus ivacaftor in people with CF who have two copies of the F508del CFTR mutation Status: Completed with results Description: This study evaluated the safety and effectiveness of the CFTR modulator drug VX-661 in combination with ivacaftor (Symdeko®). This study was for people with CF who have two copies of the F508del CFTR mutation. Age: 18 Years and Older Mutation: Two Copies F508del Fev1% Predicted: 40 to 90% Number of Visits: 6 Length of Participation: 60 days ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT02508207

Sep

CFFC Facebook Posts – September 2019 – Part 1

09/01/2019 - Clinical Trial Alerts - August 2019 – Cystic Fibrosis Foundation released several clinical trial updates in August, most of which provide reports of competed trials. 09/02/2019 - MAC Lung Infections Best Treated When Specific Bacterial Species Known, Study Finds – This study demonstrates two things. One, the advances in genetics allow for more precise diagnosis. Two, more precise diagnosis leads to more effective treatment. 09/04/2019 - Resources for Supporting Families Coping with Chronic Illness – A collection of links to a lot of good information has been compiled by Online MSW Programs. 09/05/2019 - Long-term use of Kalydeco reduces lung infections according to Registry analysis – An interesting finding drawn from the data captured in the UK CF registry. 09/06/2019 - The Kind of Friend We Deserve – Your personal support system is a critical part of overcoming the challenges presented by CF. 09/07/2019 – Living with CF Golf Tournament - One week to go until CFFC's golf tournament. Our sponsors are lined up. Southern Meadows Golf Club is in great condition. The long range weather forecast is look marvelous. All we need is you! Send an email to gsmith@cffamilyconnection.org to secure a slot in the tournament. It's not too late to sign up. 09/08/2019 - Things I Learned After Gallbladder Surgery – We know that CF does not give you a pass on the rest of the health issues that affect the rest of the population. This blog shares some observations on minor surgery. 09/09/2019 - Amikacin Liposome Therapy Has Similar Efficacy as Tobramycin for P. aeruginosa, Study Shows – Another weapon in the arsenal to combat Pseudomonas. 09/10/2019 - Cystic fibrosis carriers: What to know – This article provides information about the ...